The Cancer Research UK Clinical Magnetic Resonance Research
Group is supported jointly by the Institute of Cancer Research
and the Royal Marsden NHS Trust and works closely with the Academic
Department of Diagnostic Radiology and Joint Department of Physics.
Our research programme is directed at developing the role of magnetic
resonance imaging and spectroscopy in oncology. In addition, the
Group plays a substantial role in supporting the work of the Trust's
clinical departments in both research and service.
Much of the research of the Group is directed towards using advanced
magnetic resonance (MR) techniques to improve diagnosis and staging
in both common and rare forms of cancer. This will aid appropriate
stratification of patients for treatment and entry into trials.
By developing and evaluating new functional and metabolic measurement
techniques, we aim to establish better methods of assessing response
and of identifying recurrent disease following treatment. We are
developing and evaluating techniques for integrating MR imaging
into radiotherapy treatment planning, particularly in relation
to planning three-dimensional conformal treatments. Under the
NHS R&D Priorities in Cancer programme, we are leading a multicentre
trial of dynamic MR as a method of screening women at genetic
risk of breast cancer.
Magnetic Resonance in Breast Screening
In Partnership with the Royal Marsden NHS Trust